RT-114 — Topline data
Late 2026
~ Continues to advance RT-114 in the clinic with first participants dosed in the Phase 1a expansion cohort; additional data expected by end of 2026~Source filing
RANI biotech catalysts & pipeline
RANI THERAPEUTICS HOLDINGS INC · Data as of 2026-09-08
Upcoming catalysts
RT-114 — Topline data
2027
The study was expanded to enroll fifteen additional healthy volunteers to provide a comprehensive pharmacokinetic dataset for the RaniPill® HC as Rani moves toward initiating a Phase 1b repeat-dose study in patients with obesity by the end of 2026, with data anticipated in 2027.Source filing